Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients

Guan‐Jhou Chen(National Taiwan University Hospital), Chien‐Ching Hung(National Taiwan University), Sui‐Yuan Chang(National Taiwan University of Science and Technology), Yu‐Shan Huang(Capital Medical University), Hsin‐Yun Sun(National Taiwan University Hospital), Aristine Cheng(Far Eastern Memorial Hospital), Yi‐Ching Su(National Taiwan University Hospital), Wen‐Chun Liu(National Taiwan University Hospital), Yi‐Chia Huang(National Taiwan University Hospital), Kuan‐Yin Lin(National Taiwan University)
International Journal of Antimicrobial Agents
March 21, 2019
10.1016/j.ijantimicag.2019.03.016
Cited by 24

Related Papers

Animal models for COVID-19
|Nature|2020|877
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
|Nature|2020|856
Processing of the initiation methionine from proteins: properties of the Escherichia coli methionine aminopeptidase and its gene structure
|Journal of Bacteriology|1987|512
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics
|Nature Biomedical Engineering|2021|433
Prolonged virus shedding even after seroconversion in a patient with COVID-19
|Journal of Infection|2020|302